Abstract

Prediction of drug metabolism is an important step in the early lead optimization phase and preclinical studies. Its main purpose is to avoid late stage (Phase I–III) or post-marketing withdrawals which usually results in a significant financial loss to a pharmaceutical company. Computational methods for identification of soft-spots in the molecules (site of metabolism; SOM) and CYP450 isoforms responsible for drug metabolism have over the past ten years proved an indispensable tool towards achieving this goal. These methods can be broadly classified into i) ligand based, ii) structure based and iii) hybrid methods. In this review we discuss some of the most successful methods of SOM and isoform specificity prediction, their application domain, advantages, and limitations along with recent developments in the last 5 years in this area. Recent applications of molecular dynamics (MD), quantum mechanics (QM) and quantum mechanics/molecular mechanics (QM/MM) methodology for regioselective and isoform specific drug metabolism predictions are also discussed. Finally, a summary of these methods along with expected developments, future challenges and opportunities are discussed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.